Alexander N Meleshko

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Correction: Lutskovich et al. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. Biomedicines 2025, 13, 2130.

|Sep 27, 2025
Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma.

Dzmitry V Lutskovich, Alexander N Meleshko, Valeria M Stepanova

|Nov 29, 2023
CAR-T Cell Therapy for Classical Hodgkin Lymphoma.

Mikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko

|Jul 27, 2022
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich

|Jun 29, 2020
Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model.

Maria V Stegantseva, Veronika A Shinkevich, Elena M Tumar

|Nov 17, 2018
Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma.

Alexey V Stepanov, Oleg V Markov, Ivan V Chernikov

Pageof 1

Frequent Collaborators

4 joint publications

Dmitri O Dormeshkin

1 joint publications

Alexandr Migas

1 joint publications

Alexey V Stepanov

1 joint publications

Daniil V Gladkikh